OraSure Technologies Revenue 2010-2024 | OSUR

OraSure Technologies revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
OraSure Technologies Annual Revenue
(Millions of US $)
2023 $405
2022 $387
2021 $234
2020 $172
2019 $155
2018 $182
2017 $167
2016 $128
2015 $120
2014 $106
2013 $99
2012 $88
2011 $82
2010 $75
2009 $77
OraSure Technologies Quarterly Revenue
(Millions of US $)
2024-09-30 $40
2024-06-30 $54
2024-03-31 $54
2023-12-31 $76
2023-09-30 $89
2023-06-30 $85
2023-03-31 $155
2022-12-31 $123
2022-09-30 $116
2022-06-30 $80
2022-03-31 $68
2021-12-31 $64
2021-09-30 $54
2021-06-30 $58
2021-03-31 $59
2020-12-31 $63
2020-09-30 $48
2020-06-30 $29
2020-03-31 $32
2019-12-31 $50
2019-09-30 $36
2019-06-30 $39
2019-03-31 $30
2018-12-31 $50
2018-09-30 $46
2018-06-30 $44
2018-03-31 $42
2017-12-31 $52
2017-09-30 $42
2017-06-30 $40
2017-03-31 $33
2016-12-31 $35
2016-09-30 $32
2016-06-30 $31
2016-03-31 $29
2015-12-31 $32
2015-09-30 $30
2015-06-30 $30
2015-03-31 $27
2014-12-31 $29
2014-09-30 $28
2014-06-30 $26
2014-03-31 $24
2013-12-31 $29
2013-09-30 $25
2013-06-30 $24
2013-03-31 $21
2012-12-31 $22
2012-09-30 $22
2012-06-30 $23
2012-03-31 $21
2011-12-31 $24
2011-09-30 $22
2011-06-30 $19
2011-03-31 $17
2010-12-31 $19
2010-09-30 $19
2010-06-30 $19
2010-03-31 $18
2009-12-31 $21
2009-09-30 $22
2009-06-30 $17
2009-03-31 $17
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.272B $0.405B
OraSure Technologies, Inc. develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies is the leading supplier of oral-fluid collection devices and in vitro diagnostic assays to the employment, criminal justice, drug treatment, life insurance and public health markets for the detection of abused drugs and the antibodies to HIV. Based in Bethlehem, Pennsylvania, the Company develops, manufactures and markets oral specimen collection devices, in vitro diagnostic tests, and other medical devices.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $196.826B 25.11
Stryker (SYK) United States $146.166B 32.94
Boston Scientific (BSX) United States $145.408B 41.81
EssilorLuxottica (ESLOY) France $115.383B 0.00
Medtronic (MDT) Ireland $112.944B 16.78
Lonza Group Ag (LZAGY) Switzerland $43.849B 0.00
Haleon (HLN) United Kingdom $41.827B 27.18
GE HealthCare Technologies (GEHC) United States $38.715B 20.08
ResMed (RMD) United States $35.199B 28.92
Terumo (TRUMY) Japan $27.980B 0.00
Koninklijke Philips (PHG) Netherlands $24.250B 18.56
Zimmer Biomet Holdings (ZBH) United States $21.811B 13.89
Insulet (PODD) United States $19.347B 77.04
Baxter (BAX) United States $15.818B 10.29
Smith & Nephew SNATS (SNN) United Kingdom $11.057B 0.00
Bio-Rad Laboratories (BIO) United States $9.586B 32.58
BellRing Brands (BRBR) United States $9.323B 37.51
Demant (WILYY) Denmark $8.735B 0.00
Lantheus Holdings (LNTH) United States $6.360B 14.78
ICU Medical (ICUI) United States $4.012B 38.20
Prestige Consumer Healthcare (PBH) United States $3.882B 19.31
Haemonetics (HAE) United States $3.691B 18.01
Envista Holdings (NVST) United States $3.413B 25.42
Perrigo (PRGO) Ireland $3.252B 9.57
Shandong Weigao Medical Polymer (SHWGF) China $3.010B 0.00
QuidelOrtho (QDEL) United States $2.807B 18.07
GN Store Nord (GNNDY) Denmark $2.585B 16.58
Neogen (NEOG) United States $2.508B 28.90
LeMaitre Vascular (LMAT) United States $2.227B 54.13
AtriCure (ATRC) United States $1.876B 0.00
Green Thumb Industries (GTBIF) United States $1.572B 27.52
AdaptHealth (AHCO) United States $1.416B 10.11
InMode (INMD) Israel $1.410B 8.48
BioLife Solutions (BLFS) United States $1.213B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.205B 0.00
Owens & Minor (OMI) United States $1.124B 8.78
Curaleaf Holdings (CURLF) Canada $0.981B 0.00
Phibro Animal Health (PAHC) United States $0.843B 14.87
CeriBell (CBLL) United States $0.754B 0.00
Evolus (EOLS) United States $0.666B 0.00
Capricor Therapeutics (CAPR) United States $0.623B 0.00
VAREX IMAGING (VREX) United States $0.557B 24.58
Omeros (OMER) United States $0.541B 0.00
Surmodics (SRDX) United States $0.527B 0.00
Cresco Labs (CRLBF) United States $0.434B 0.00
Verano Holdings (VRNOF) United States $0.434B 0.00
ZimVie (ZIMV) United States $0.394B 33.23
Valneva SE (VALN) France $0.355B 0.00
Quanterix (QTRX) United States $0.342B 0.00
Cerus (CERS) United States $0.332B 0.00
Viemed Healthcare (VMD) United States $0.317B 30.18
Biote (BTMD) United States $0.306B 6.71
Sanara MedTech (SMTI) United States $0.285B 0.00
High Tide (HITI) Canada $0.250B 103.00
Zynex (ZYXI) United States $0.245B 51.20
Canopy Growth (CGC) Canada $0.237B 0.00
Sanuwave Health (SNWV) United States $0.226B 3.18
Aurora Cannabis (ACB) Canada $0.211B 0.00
Utah Medical Products (UTMD) United States $0.211B 14.56
Organigram Holdings (OGI) Canada $0.196B 0.00
Brainsway (BWAY) Israel $0.192B 102.30
MacroGenics (MGNX) United States $0.188B 0.00
TerrAscend (TSNDF) Canada $0.168B 0.00
TriSalus Life Sciences (TLSI) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.149B 18.77
Veru (VERU) United States $0.143B 0.00
Jin Medical (ZJYL) China $0.143B 0.00
Quipt Home Medical (QIPT) United States $0.130B 0.00
Fonar (FONR) United States $0.096B 10.87
Oramed Pharmaceuticals (ORMP) United States $0.092B 0.00
INLIF (INLF) $0.078B 0.00
InterCure (INCR) Israel $0.077B 0.00
Exagen (XGN) United States $0.070B 0.00
Rockwell Medical (RMTI) United States $0.069B 35.33
Jushi Holdings (JUSHF) United States $0.063B 0.00
Ayr Wellness (AYRWF) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.056B 0.00
Apyx Medical (APYX) United States $0.052B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Modular Medical (MODD) United States $0.042B 0.00
Safety Shot (SHOT) United States $0.033B 0.00
Nephros (NEPH) United States $0.017B 0.00
Innovative Eyewear (LUCY) United States $0.014B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Meihua Medical Technologies (MHUA) China $0.008B 0.00
Allurion Technologies (ALUR) United States $0.008B 0.00
Trinity Biotech (TRIB) Ireland $0.006B 0.00
Agape ATP (ATPC) $0.005B 0.00
IM Cannabis (IMCC) Canada $0.005B 0.00
Sharps Technology (STSS) United States $0.004B 0.00
Senestech (SNES) United States $0.003B 0.00
Akanda (AKAN) United Kingdom $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
United-Guardian (UG) United States $0.000B 14.11
SNDL (SNDL) Canada $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00